Marcus Maurer: Clinical Trials

4 trials sponsored by Marcus Maurer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 2 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Completed 1
Phase 41Completed 1

Follow Marcus Maurer: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Profiling Urticaria for the Identification of Subtypes
Non-autoreactive Chronic Spontaneous Urticaria, Autoimmune Chronic Spontaneous Urticaria
CompletedMarcus Maurer1952011-07-012015-07-28
Study on Mastocytosis for Rupatadine Treatment
Rupatadin - Mastocytosis
Phase 2 / Phase 3CompletedMarcus Maurer302010-09-012016-11-03
Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria
Desloratadine - Urticaria
Phase 4CompletedMarcus Maurer302009-08-012011-10-03
Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria
Miltefosine, Placebo - Chronic Urticaria
Phase 2TerminatedMarcus Maurer762008-09-012016-12-26

Conditions studied

Urticaria (2)  ·  Chronic Urticaria (1)  ·  Mastocytosis (1)

Interventions

desloratadine (1)  ·  miltefosine (1)

Countries

Germany (4)

Top investigators

Markus Magerl, MD (1)

NIH funding

2008 (1)